Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($2.02), versus ($1.88) reported last year. Revenue for the quarter came in at $436 thousand versus the consensus estimate of $991 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.